NCT04213664 - Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma. | Biotech Hunter

Enrollment

4,666

Participants

Timeline

Start Date

December 31, 2019

Primary Completion Date

January 2, 2020

Study Completion Date

January 31, 2020

Conditions

Renal Cell CarcinomaProgressionLymphocyte DisorderMonocytosisLocal Disease

Interventions

OTHER

prognosis

cancer and overall survival cancer specific survival cancer and recurrence-free survival cancer and disease-free survival lymphocyte to monocyte ratio in non-metastatic renal cancer and progression-free survival

Trial Locations (1)

08208

RECRUITING

Corporacion Parc Tauli, Sabadell